Workflow
Opus Genetics, Inc.(IRD) - 2025 Q4 - Annual Results
2026-02-19 21:02
Exhibit 10.1 Execution Version SECURITIES PURCHASE AGREEMENT BY AND AMONG OPUS GENETICS, INC. AND THE PURCHASERS AS SET FORTH HEREIN FEBRUARY 13, 2026 TABLE OF CONTENTS | 1. | Definitions | | 1 | | --- | --- | --- | --- | | 2. | | Purchase and Sale of Securities | 4 | | | 2.1 | Purchase and Sale | 4 | | | 2.2 | Closing | 4 | | 3. | | Representations and Warranties of the Company | 5 | | | 3.1 | Subsidiaries; Organization and Power | 5 | | | 3.2 | Capitalization | 5 | | | 3.3 | Registration Rights | 6 | | | ...
Rimini Street(RMNI) - 2025 Q4 - Annual Report
2026-02-19 21:02
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☑ Annual report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934 For the Fiscal Year Ended December 31, 2025 ☐ Transition report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period from to Commission File Number 001-37397 Rimini Street, Inc. (Exact name of registrant as specified in its charter) Delaware 36-4880301 (State or other jurisdiction of inc ...
Comfort Systems USA(FIX) - 2025 Q4 - Annual Results
2026-02-19 21:02
Exhibit 99.1 CONTACT:Julie Shaeff, Chief Accounting Officer 9753 Katy Freeway, ir@comfortsystemsusa.com; 713-830-9687 Houston, Texas 77024 Suite 700 713-830-9600 FOR IMMEDIATE RELEASE COMFORT SYSTEMS USA REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS Houston, TX — February 19, 2026 — Comfort Systems USA, Inc. (NYSE: FIX) (the "Company") today reported results for the quarter and annual period ended December 31, 2025. For the quarter ended December 31, 2025, net income was $330.8 million, or $9.37 per dil ...
Avis Budget Group(CAR) - 2025 Q4 - Annual Report
2026-02-19 21:02
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-10308 AVIS BUDGET GROUP, INC. (Exact name of Registrant as specified in its charter) Delaware 06-0918165 (State or other jurisdiction of incorporat ...
Weave munications(WEAV) - 2025 Q4 - Annual Results
2026-02-19 21:01
• Total revenue was $63.4 million, representing a 17.0% year-over-year increase compared to $54.2 million in the fourth quarter of 2024. • GAAP gross margin was 72.7%, compared to 72.1% in 2024. • Non-GAAP gross margin was 73.3%, compared to 72.6% in 2024. • GAAP loss from operations was $2.2 million, compared to $7.4 million in the fourth quarter of 2024. • Non-GAAP income from operations was $2.3 million, compared to $1.8 million in the fourth quarter of 2024. • GAAP net loss was $1.8 million, or $0.02 pe ...
Perdoceo Education (PRDO) - 2025 Q4 - Annual Results
2026-02-19 21:01
*See GAAP (U.S. generally accepted accounting principles) to non-GAAP reconciliations attached to this press release. PRDO ANNOUNCES 4Q25 AND FULL YEAR RESULTS …PG 1 PERDOCEO EDUCATION CORPORATION REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS Schaumburg, IL. (February 19, 2026) – Perdoceo Education Corporation (NASDAQ: PRDO), a provider of postsecondary education programs through its academic institutions, today reported operating and financial results for the quarter and year ended December 31, 2025. " ...
Aeglea BioTherapeutics, Inc.(AGLE) - 2025 Q4 - Annual Report
2026-02-19 21:01
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 _________________________________________________________ FORM 10-K _________________________________________________________ x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from______ to Commission file number 001-37722 ___ ...
Spyre Therapeutics(SYRE) - 2025 Q4 - Annual Report
2026-02-19 21:01
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 _________________________________________________________ FORM 10-K _________________________________________________________ x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from______ to Commission file number 001-37722 ___ ...
Applied Materials(AMAT) - 2026 Q1 - Quarterly Report
2026-02-19 21:01
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended January 25, 2026 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-06920 Applied Materials, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdi ...
United Insurance(ACIC) - 2025 Q4 - Annual Results
2026-02-19 21:01
Exhibit 99.1 FOR IMMEDIATE RELEASE AMERICAN COASTAL INSURANCE CORPORATION REPORTS FINANCIAL RESULTS FOR ITS FOURTH QUARTER AND YEAR ENDED DECEMBER 31, 2025 Company to Host Quarterly Conference Call at 5:00 P.M. ET on February 19, 2026 The information in this press release should be read in conjunction with an earnings presentation that is available on the Company's website at investors.amcoastal.com/events-and-presentations. St. Petersburg, FL - February 19, 2026: American Coastal Insurance Corporation (Nas ...